BACKGROUND The del Nido cardioplegia was devised and introduced as a single dose cardioplegia for myocardial protection in congenital heart surgery by Petro del Nido and team. The most commonly used cardioplegia in adult cardiac surgery was multidose blood cardioplegia which has to be repeated every 25 to 30 minutes to maintain cardiac arrest. For this, the surgery has to be interrupted leading to prolonged cardiopulmonary bypass and aortic cross clamp time. With promising results of del Nido cardioplegia in adult cardiac surgery, more and more centres adopted this single dose cardioplegia in adult cardiac surgery. We retrospectively analysed the safety and efficacy of del Nido cardioplegia and compared them with those of conventional blood cardioplegia in isolated coronary artery bypass surgery. METHODS We have been using multidose conventional blood cardioplegia (CBCP) solution for all our cardiac surgeries. We changed the cardioplegia protocol to single dose del Nido cardioplegia (DNCP) solution in October 2016. We collected the preoperative, intraoperative and post-operative data of 100 patients in each group, who underwent elective isolated coronary artery bypass surgery. RESULTS The baseline demographic features, pre- and post-operative cardiac function, number of coronary arteries involved, and comorbidities were similar in both groups. There was a statistically significant reduction in cardiopulmonary bypass time (77.16 ± 13.13 minutes vs. 121.69 ± 28.18 minutes, P-value < .00001) and aortic cross clamp time (57.71 ± 10.6 minutes vs. 77.26 ± 20.29 minutes, p value < .00001) in the DNCP group. The total dose of cardioplegia solution required was significantly less in DNCP group (1000 mL vs. 2393.56 ± 592.42 mL, P-value < .00001). The mean post-operative hospital stay in DNCP group was 7.87 ± 1.25 days as compared to 12.49 ± 1.29 days in CBCP group with a P-value < .00001. CONCLUSIONS The del Nido cardioplegia solution is associated with shorter cardiopulmonary bypass and aortic cross clamp time, less volume of cardioplegia solution and shorter mean hospital stay. The del Nido cardioplegia can be used in adult cardiac surgery with the same safety of conventional blood cardioplegia in adult isolated coronary artery bypass surgery. KEYWORDS Del Nido Cardioplegia, Isolated Coronary Artery Bypass Surgery, Myocardial Protection, Cardiopulmonary Bypass Time, Aortic Cross Clamp Time
Aims:We evaluated the role of packed red blood cell (PRBC) transfusion on the causation of necrotising enterocolitis (NEC) in neonates. Methods:In a retrospective observational study (April 08-March 09), we compared neonates who developed NEC after PRBC transfusion (transfusion group) to neonates who developed NEC without blood transfusion (controls). Results:Over the one year period, 20 neonates developed NEC (2/1000 live births). Gestation less than 30 weeks(75%) and birth weight less than 1500 grams (93.3%) were the most common risk factors. Nine (55.6%) babies had received a recent PRBC transfusion. The gestational age of the transfusion group (27.5 weeks) was comparable to the control group (26.89 weeks). NEC developed at a mean post natal age of 42 days in the transfusion group against 19.2 days in controls. 50% of babies in the transfusion group were Black African ethnicity compared to 14.3% in the control group. Perforating NEC developed in 22.2% of babies in the transfusion group (42.8% in the control group). An abnormal antenatal ultrasound scan (23.1%), maternal smoking (25%), antepartum haemorrhage (21.4%), chorioamnionitis (33.3%) and emergency caesarean section delivery (40%) were moderately associated with NEC, but were not significantly different between the groups. There was a bimodal pattern of onset. Early symptoms developed within 72 hours (mean 2.6 days) of the packed red cell transfusion in five (55.6%) babies and late symptoms developed at mean 10.6 days. Conclusions:There is a close association between blood transfusion and NEC. Black African babies and older babies are at increased risk.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.